ORF Biologics
ORF Biologics, Inc.
ORF Biologics pioneers next-generation biologics and cutting-edge technologies for research and therapeutic applications.
orfbiologics.com · Tiffin, IA
Funding event
The round itself, as filedInferred stageSeed
Sold of offered$1.7M of $2.5M
Filed2026-07-31
Days since filing65
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-07-23
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Steven MichalicekDirector
- Anant KamathExecutive Officer · Director
- Jay KamathExecutive Officer
- Sara TernesExecutive Officer
- Nicholas TaiberDirector
- Roger A. BakerDirector
- John R. HuiskampDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged69.4% sold2.4 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-240
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-03, against 71 in the 28 days before.